EMA Authorised: Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris (emtricitabine;rilpivirine hydrochloride;tenofovir alafenamide fumarate) — Viatris Limited

View source ↗

Summary

The European Medicines Agency authorised a fixed-dose combination HIV therapy containing emtricitabine, rilpivirine and tenofovir alafenamide, marketed by Viatr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Tenofovir alafenamide (tenofovir alafenamide)
• rilpivirine (rilpivirine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 12/02/2026